J. O’Connell

发表

Novel Nonnucleoside Inhibitor of Hepatitis C Virus RNA-Dependent RNA Polymerase

A. Gopalsamy, J. Ellingboe, A. Howe, 2004, Antimicrobial Agents and Chemotherapy.

Molecular Mechanism of a Thumb Domain Hepatitis C Virus Nonnucleoside RNA-Dependent RNA Polymerase Inhibitor

R. Chopra, A. Agarwal, A. Howe, 2006, Antimicrobial Agents and Chemotherapy.

Functional, Biophysical, and Structural Bases for Antibacterial Activity of Tigecycline

T. Rush, J. O'Connell, E. Feyfant, 2006, Antimicrobial Agents and Chemotherapy.

Tigecycline MIC Testing by Broth Dilution Requires Use of Fresh Medium or Addition of the Biocatalytic Oxygen-Reducing Reagent Oxyrase To Standardize the Test Method

J. O'Connell, P. Bradford, M. Young, 2005, Antimicrobial Agents and Chemotherapy.

The Discovery of Pyrano[3,4‐b]indole‐Based Allosteric Inhibitors of HCV NS5B Polymerase with In Vivo Activity

N. Kneteman, A. Howe, J. O'Connell, 2008, ChemMedChem.

Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796

R. Chopra, J. Bard, G. Krishnamurthy, 2008, Antimicrobial Agents and Chemotherapy.

Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.

Boris Feld, A. Gopalsamy, Kitae Lim, 2004, Journal of medicinal chemistry.

Antipicornavirus activity of SCH 47802 and analogs: in vitro and in vivo studies.

J. O'Connell, E. Rozhon, A. Skelton, 1996, Antiviral research.

Use of Ribotyping To Retrospectively Identify Methicillin-Resistant Staphylococcus aureus Isolates from Phase 3 Clinical Trials for Tigecycline That Are Genotypically Related to Community-Associated Isolates

J. O'Connell, P. Bradford, B. Kreiswirth, 2005, Antimicrobial Agents and Chemotherapy.

Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types.

J. O'Connell, G. Mccracken, R. Dagan, 1997, The Pediatric infectious disease journal.

RFI-641, a Potent Respiratory Syncytial Virus Inhibitor

A. Gazumyan, B. Feld, J. O'Connell, 2002, Antimicrobial Agents and Chemotherapy.

Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes.

E. Arnold, J. O'Connell, E. Rozhon, 1997, Structure.

Anti‐HCV therapies in chimeric scid‐Alb/uPA mice parallel outcomes in human clinical application

Z. Ni, D. Tyrrell, A. Weiner, 2006, Hepatology.

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti‐hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

D. Douglas, Jamie T. Lewis, G. Lund, 2009, Hepatology.

Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors.

F. Moy, A. Gopalsamy, Kitae Lim, 2004, Journal of medicinal chemistry.

Specific Inhibition of Human Cytomegalovirus Glycoprotein B-Mediated Fusion by a Novel Thiourea Small Molecule

B. Feld, J. O'Connell, J. Bloom, 2004, Journal of Virology.

Identification of Small Molecule Compounds That Selectively Inhibit Varicella-Zoster Virus Replication

J. Cohen, K. Curran, B. Feld, 2003, Journal of Virology.

SCH 48973: a potent, broad-spectrum, antienterovirus compound

J. O'Connell, J. Modlin, E. Rozhon, 1997, Antimicrobial agents and chemotherapy.

SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.

E. Arnold, J. O'Connell, G. Miller, 1993, Antiviral research.

Development of Antiviral Agents for Picornavirus Infections

J. O'Connell, J. Schwartz, P. Grint, 1995 .

Elongation of Synthetic RNA Templates by Hepatitis C Virus NS5B Polymerase*

R. Chopra, J. O'Connell, Cuihua Liu, 2004, Journal of Biological Chemistry.

In Vitro and In Vivo Activities of Novel 6-Methylidene Penems as β-Lactamase Inhibitors

J. O'Connell, T. Mansour, P. Bradford, 2004, Antimicrobial Agents and Chemotherapy.